Condition
Unresectable Colorectal Liver Metastases
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 1 (3)
Trial Status
Not Yet Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07406126Not Yet Recruiting
Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases
NCT04062721Phase 1Not Yet RecruitingPrimary
Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases
NCT05692037Phase 1UnknownPrimary
Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases
NCT01042691Phase 1CompletedPrimary
Isolated Liver Perfusion With Oxaliplatin
Showing all 4 trials